210-716-7 | Sigma-Aldrich

XP725 Antibody Number-Lot Number 071M4826

.4 685 686 687 688 709 710 711 712 733 734 735 736 757 758 759 760 8.5 689 690 691 692 713 714 715 716 737 738 739 740 761 762 763 764 8.6 693 694 695 696 717 718 719

Product Information Sheet - CS0210

Gynaecol., 17, 707-716 (2003). 7. Strauss, D. S., Glass, C. K., Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev., 21, 185-210 (2001). 8.

App Note: Scalability Studies for Millistak+® HC and Millistak+® HC Pro Micro 20 Devices

Manufacturing Processes: Current State and Future Perspectives. Biotechnology and Bioengineering, 698-716. Merck KGaA Frankfurter Strasse 250 64293 Darmstadt, Germany © 2023 Merck KGaA, Darmstadt, Germany

Product Information Sheet-05080576001

315 959 001 100 ml, 4 x 25 ml 03 315 843 001 DNase I recombinant, RNase-free 10,000 U, 10 U/μl 04 716 728 001 MagNA Lyser Green Beads 100 tubes, prefilled with ceramic beads 03 358 941 001 1

High Pure miRNA Isolation Kit

, 220 V, 220 V 03 358 976 001 Reagents , kits DNase I recombinant, RNase-free 10,000 U, 10 U/μl 04 716 728 001 Water, PCR Grade 25 ml, 25 x 1 ml 03 315 932 001 25 ml, 1 x 25

Calbiochem Biologics 29.1

O’Neill, M.J., et al. 1997. Brain Res. 776600,, 170; Clemens, J.A., et al. 1993. Stroke 2244,, 716. Myeloperoxidase Inhibitor I A benzoic acid hydrazide analog that acts as a potent, irreversible

XP725 Antibody List Lot 089K4791

P3118 56042 Uso1 M NP_062252.1 n/d n/d y 689 SMAC/Diablo S0941 56616 DIABLO P NP_063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/

XP725 Antibody List Lot 129K4831

P3118 56042 Uso1 M NP_062252.1 n/d n/d y 689 SMAC/Diablo S0941 56616 DIABLO P NP_063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/

XP725 Antibody List Lot 129K4830

P3118 56042 Uso1 M NP_062252.1 n/d n/d y 689 SMAC/Diablo S0941 56616 DIABLO P NP_063940.1 y y n/d 716 TOM22 T6319 56993 TOMM22 M NP_064628.1 y n/d n/d 756 VGLUT 1 V0389 57030 SLC17A7 P NP_064705.1 y n/

XP725 Worksheet for Lot Number 071M4826

pSer139 H5912711 4 3 5 7 712 4 3 5 8 phosphoHistone H2AX pSer139 H5912 713 4 3 6 1 Histone H3 pSer10 H6409 714 4 3 6 2 Histone H3 pSer10 H6409 715 4 3 6 3 Histone H3 pSer28 H9908 716 4 3

List of Antibodies

peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M y n/d n/d 207 Cytokeratin 8.13 C6909 M y n/d n/d 208 Cytokeratin peptide 13 C0791 M y n/d n/d 209 Cytokeratin Peptide 17 C9179 M y n/d y 210 Cytokeratin

Stem Cell and Specialty Cell Culture Product Guide

Pur R IgG 2a 100 µg MAB1147 Flk-1 (VEGFR-2, KDR) H, M, Po IP, WB, IC Sera Rabbit 100 µL 07-716 LEO1, polyclonal H WB Sera Rabbit 100 µL AB10190 MEOX1, polyclonal M, H, R WB

XP725 Antibody List

TNF NP_000585.2 M y n/d n/d 715 Tob T2948 10140, 10766 TOB1,TOB2 NP_005740.1,NP_057356.1 M y n/d n/d 716 TOM22 T6319 56993 TOMM22 NP_064628.1 M y n/d n/d 717 Topoisomerase-I T8573 7150 TOP1 NP_003277.1 M

Cytoskeletal Signaling Antibodies, Reagents and Kits

MW (kDa) Reduced Conditions 210 165 130 150 135 120 125 120 130 95 105 220 110 MW (kDa) Non-Reduced Conditions 200 160 150 140 155 140 150 145 110 90 90 210 100 Integrin Subunit α1 α2 α3

XP725 Antibody List 013M4793

6 3 4 6 0 8 715 Tob T2948 10140, 10766 TOB1,TOB2 NP_005740.1,NP_057356.1 M y n/d n/d 716 TOM22 T6319 56993 TOMM22 NP_064628.1 M y n/d n/d 717 Topoisomerase-I T8573 7150 TOP1 NP_003277.1 M

Halal Certificate

Halal-ID Product Certificate # 715. HEXYL ALCOHOL NATURAL, 98%, FCC, FG W256714 A95057 HC-23SIJJ86 716. HEXYL BENZOATE FG W369101 A68197 HC-23SIJ604 717. HEXYL BUTYRATE 98%, FG W256803 B47388 HC-23SINW75

Halal Certificate

Halal-ID Product Certificate # 715. HEXYL ALCOHOL NATURAL, 98%, FCC, FG W256714 A95057 HC-22SI5M08 716. HEXYL BENZOATE FG W369101 A68197 HC-22SIQK25 717. HEXYL BUTYRATE 98%, FG W256803 B47388 HC-22SI8A96